SCHEMBL4159757

SCHEMBL4159757

Cc1cc(C#N)cc(C(=O)NCC2CCO2)c1NC(=O)c1cc(Br)nn1-c1ncccc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.38
ALDH1A1 P00352 2/20 0.38
EGLN1 Q9GZT9 2/20 0.38
DHODH Q02127 1/20 0.38
SMO Q99835 2/20 0.37
FASN P49327 1/20 0.37
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
TSHR P16473 1/20 0.34
HPGD P15428 1/20 0.34
TNF P01375 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
MALT1 Q9UDY8 1/20 0.34
RAB9A P51151 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PDE4A P27815 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2138881 0.92 P2RX7 (0.39) NTRK1EGLN1DHODHMALT1PDE4A
SCHEMBL4155986 0.91 SMO (0.40) NTRK1ALDH1A1DHODHSMOPOLB
SCHEMBL14524810 0.88 DHODH (0.41) NTRK1EGLN1DHODHMALT1PDE4A
SCHEMBL11893154 0.88 DHODH (0.41) NTRK1EGLN1DHODHTNFIRAK4
SCHEMBL1533505 0.88 CHRM4 (0.38) EGLN1DHODHIRAK4MALT1
SCHEMBL4162093 0.86 NTRK1 (0.41) NTRK1ALDH1A1DHODHSMOPOLB
SCHEMBL11893160 0.86 DHODH (0.40) NTRK1EGLN1DHODHMALT1PDE4B
SCHEMBL950199 0.86 DHODH (0.42) ALDH1A1DHODHMAPTMALT1PDE4A
Cyantraniliprole SCHEMBL29354965 0.85 DHODH (0.42) EGLN1DHODHMALT1PDE4APDE4B
Cyantraniliprole SCHEMBL166640 0.85 DHODH (0.42) EGLN1DHODHMALT1PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812421-B9 ANTHRANILAMIDE INSECTICIDES DU PONT (US) 2013-09-25 EP claimed
EP-1812421-B1 ANTHRANILAMIDE INSECTICIDES DU PONT (US) 2013-04-24 EP claimed
US-20090133318-A1 Anthranilamide insecticides E. I. DU PONT DE NEMOURS AND COMPANY 2009-05-28 US claimed
EP-2564706-A1 Anthranilamide insecticides E. I. du Pont de Nemours and Company (US) 2013-03-06 EP disclosed
US-20090133318-A1 Anthranilamide insecticides E. I. DU PONT DE NEMOURS AND COMPANY 2009-05-28 US disclosed
EP-1812421-A2 ANTHRANILAMIDE INSECTICIDES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2007-08-01 EP disclosed
WO-2006055922-A2 ANTHRANILAMIDE INSECTICIDES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090133318-A1 Anthranilamide insecticides C3AR1, C5, C1S NTRK1 3126/4885ALDH1A1 937/4885EGLN1 1750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.